[{"id":"appendiceal","kind":"cancer","name":"Appendiceal cancer and pseudomyxoma peritonei","route":"/cancers/appendiceal/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"stateOfArt","before":"[\"CRS-HIPEC turned PMP from a fatal disease into one with long survival for low-grade histology.\", \"Grade, not stage, drives therapy: the 2024 randomised trial ended routine chemotherapy for low-grade mucinous carcino...","after":"[\"CRS-HIPEC turned PMP from a disease with no effective treatment into one with long survival for low-grade histology.\", \"Grade, not stage, drives therapy: the 2024 randomised trial ended routine chemotherapy for low-..."}]},{"id":"appendiceal","kind":"cancer","name":"Appendiceal cancer and pseudomyxoma peritonei","route":"/cancers/appendiceal/","commit":"71e4eef6e1","date":"2026-09-08","author":"Jude Gomila","message":"Gap audit and gap-fill data: 33 cancers, 87 products, 20 targets, 25 technologies, 12 terms, 18 collections","file":"src/data/spikes/gap-cancers.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"group"},{"field":"wikipedia"},{"field":"aka"},{"field":"burden"},{"field":"tldr"},{"field":"summary"},{"field":"subtypes"},{"field":"biomarkers"},{"field":"standardOfCare"},{"field":"stateOfArt"},{"field":"history"},{"field":"pipeline"},{"field":"openProblems"},{"field":"targets"},{"field":"technologies"},{"field":"drugs"},{"field":"pathways"},{"field":"companies"},{"field":"terms"},{"field":"links"},{"field":"tags"}]}]